SenzaGen Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
33
- Stock Symbol
-
SENZA
- Investments
-
2
- Share Price
-
$0.67
- (As of Thursday Closing)
SenzaGen General Information
Description
SenzaGen AB markets sells, and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its laboratory and licensed Contract Research Organizations (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products, and dyes. It operates in five market segments- Cosmetics, Chemicals, Medical devices, Pharmaceuticals, and Nutrition/food additives. The majority is from the Pharmaceuticals segment. Geographically it operates in North America, Europe, APAC, and RoW, the majority is from Europe.
Contact Information
Website
www.senzagen.comCorporate Office
- Medicon Village, Building 401
- Scheelevägen 2
- 223 81 Lund
- Sweden
Corporate Office
- Medicon Village, Building 401
- Scheelevägen 2
- 223 81 Lund
- Sweden
SenzaGen Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.67 | $0.68 | $0.53 - $0.91 | $19.7M | 29.5M | 21.9K | -$0.08 |
SenzaGen Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 18,377 | 15,410 | 23,067 | 17,731 |
Revenue | 5,194 | 4,692 | 4,117 | 1,796 |
EBITDA | (1,934) | (1,026) | (1,546) | (3,162) |
Net Income | (1,935) | (2,079) | (2,456) | (3,650) |
Total Assets | 11,143 | 9,723 | 11,499 | 14,785 |
Total Debt | 400 | 167 | 116 | 79 |
SenzaGen Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
SenzaGen Patents
SenzaGen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220026411-A1 | Analytical methods and arrays for use in the same | Pending | 03-Jan-2019 | ||
EP-3906323-A2 | Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method | Pending | 03-Jan-2019 | ||
AU-2020205151-A1 | Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method | Inactive | 03-Jan-2019 | ||
CA-3123717-A1 | Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method | Pending | 03-Jan-2019 | ||
GB-201715445-D0 | Novel cell line and uses thereof | Inactive | 25-Sep-2017 | C12Q1/6876 |
SenzaGen Signals
SenzaGen Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
SenzaGen Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Toxhub | 11-Nov-2022 | Consulting Services (B2B) | |||
VitroScreen | 02-Nov-2021 | Merger/Acquisition | Other Commercial Services |
SenzaGen Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Toxhub | Consulting Services (B2B) | Rome, Italy | 2020 |
VitroScreen | Other Commercial Services | Milan, Italy |
SenzaGen FAQs
-
When was SenzaGen founded?
SenzaGen was founded in 2010.
-
Where is SenzaGen headquartered?
SenzaGen is headquartered in Lund, Sweden.
-
What is the size of SenzaGen?
SenzaGen has 33 total employees.
-
What industry is SenzaGen in?
SenzaGen’s primary industry is Laboratory Services (Healthcare).
-
Is SenzaGen a private or public company?
SenzaGen is a Public company.
-
What is SenzaGen’s stock symbol?
The ticker symbol for SenzaGen is SENZA.
-
What is the current stock price of SenzaGen?
As of 31-Oct-2024 the stock price of SenzaGen is $0.67.
-
What is the current market cap of SenzaGen?
The current market capitalization of SenzaGen is $19.7M.
-
What is SenzaGen’s current revenue?
The trailing twelve month revenue for SenzaGen is $5.19M.
-
What is SenzaGen’s annual earnings per share (EPS)?
SenzaGen’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »